Preliminary scientific tests indicate conolidine might inhibit specific ion channels, cutting down neuronal excitability and restricting suffering signals. This system is particularly related in neuropathic ache, where by irregular signaling results in persistent distress. Furthermore, conolidine seems to influence G protein-coupled receptor (GPCR)